Bruce Jackson
Stock Analyst at Benchmark
(0.65)
# 2,797
Out of 4,479 analysts
89
Total ratings
19.18%
Success rate
-29.07%
Average return
Main Sectors:
23 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GDTC CytoMed Therapeutics | Reiterates: Speculative Buy | $5 | $2.00 | +150.00% | 3 | Jun 11, 2024 | |
| CDIO Cardio Diagnostics Holdings | Maintains: Speculative Buy | $1.35 → $2 | $0.54 | +270.37% | 4 | Jun 6, 2024 | |
| GNLX Genelux | Reiterates: Speculative Buy | $25 | $1.84 | +1,258.70% | 6 | Jun 3, 2024 | |
| UNCY Unicycive Therapeutics | Reiterates: Speculative Buy | $3 | $0.54 | +455.56% | 6 | Jun 3, 2024 | |
| KNW Know Labs | Reiterates: Speculative Buy | $1 | $0.41 | +146.12% | 2 | May 29, 2024 | |
| RVPH Reviva Pharmaceuticals Holdings | Reiterates: Speculative Buy | $17 | $1.19 | +1,328.57% | 3 | May 28, 2024 | |
| HUMA Humacyte | Reiterates: Buy | $15 | $5.37 | +179.33% | 7 | May 24, 2024 | |
| CLNN Clene | Reiterates: Buy | $5 | $0.36 | +1,300.56% | 6 | May 23, 2024 | |
| BLTE Belite Bio | Reiterates: Buy | $57 | $45.82 | +24.40% | 6 | May 16, 2024 | |
| BIOL BIOLASE | Reiterates: Speculative Buy | $0.4 | $0.11 | +271.06% | 3 | May 14, 2024 | |
| NEO NeoGenomics | Reiterates: Buy | $18 | $13.93 | +29.22% | 4 | May 1, 2024 | |
| TNON Tenon Medical | Maintains: Speculative Buy | $5 → $3 | $0.72 | +316.61% | 2 | Apr 15, 2024 | |
| OCX OncoCyte | Reiterates: Speculative Buy | $5 | $2.95 | +69.49% | 3 | Apr 15, 2024 | |
| MODD Modular Medical | Reiterates: Speculative Buy | $5 | $1.52 | +228.95% | 4 | Mar 21, 2024 | |
| EXAS Exact Sciences | Upgrades: Buy | $91 | $42.43 | +114.47% | 4 | Jan 2, 2024 | |
| SKIN The Beauty Health Company | Downgrades: Hold | n/a | $1.84 | - | 7 | Nov 14, 2023 | |
| SEEL Seelos Therapeutics | Maintains: Speculative Buy | $960 → $240 | $0.62 | +38,672.21% | 3 | Sep 21, 2023 | |
| STAA STAAR Surgical Company | Downgrades: Hold | n/a | $47.42 | - | 4 | Sep 15, 2023 | |
| BFRI Biofrontera | Reiterates: Buy | $18 | $0.89 | +1,917.94% | 5 | Aug 31, 2023 | |
| HBIO Harvard Bioscience | Reiterates: Speculative Buy | $7 | $2.78 | +151.80% | 3 | Jun 22, 2023 | |
| HOTH Hoth Therapeutics | Reiterates: Speculative Buy | $5 | $0.92 | +446.21% | 2 | Jun 20, 2023 | |
| VNRX VolitionRx | Downgrades: Hold | n/a | $0.62 | - | 1 | Feb 1, 2023 | |
| HSCS Heart Test Laboratories | Initiates: Speculative Buy | $800 | $5.06 | +15,710.28% | 1 | Aug 8, 2022 |
CytoMed Therapeutics
Jun 11, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $2.00
Upside: +150.00%
Cardio Diagnostics Holdings
Jun 6, 2024
Maintains: Speculative Buy
Price Target: $1.35 → $2
Current: $0.54
Upside: +270.37%
Genelux
Jun 3, 2024
Reiterates: Speculative Buy
Price Target: $25
Current: $1.84
Upside: +1,258.70%
Unicycive Therapeutics
Jun 3, 2024
Reiterates: Speculative Buy
Price Target: $3
Current: $0.54
Upside: +455.56%
Know Labs
May 29, 2024
Reiterates: Speculative Buy
Price Target: $1
Current: $0.41
Upside: +146.12%
Reviva Pharmaceuticals Holdings
May 28, 2024
Reiterates: Speculative Buy
Price Target: $17
Current: $1.19
Upside: +1,328.57%
Humacyte
May 24, 2024
Reiterates: Buy
Price Target: $15
Current: $5.37
Upside: +179.33%
Clene
May 23, 2024
Reiterates: Buy
Price Target: $5
Current: $0.36
Upside: +1,300.56%
Belite Bio
May 16, 2024
Reiterates: Buy
Price Target: $57
Current: $45.82
Upside: +24.40%
BIOLASE
May 14, 2024
Reiterates: Speculative Buy
Price Target: $0.4
Current: $0.11
Upside: +271.06%
NeoGenomics
May 1, 2024
Reiterates: Buy
Price Target: $18
Current: $13.93
Upside: +29.22%
Tenon Medical
Apr 15, 2024
Maintains: Speculative Buy
Price Target: $5 → $3
Current: $0.72
Upside: +316.61%
OncoCyte
Apr 15, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $2.95
Upside: +69.49%
Modular Medical
Mar 21, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $1.52
Upside: +228.95%
Exact Sciences
Jan 2, 2024
Upgrades: Buy
Price Target: $91
Current: $42.43
Upside: +114.47%
The Beauty Health Company
Nov 14, 2023
Downgrades: Hold
Price Target: n/a
Current: $1.84
Upside: -
Seelos Therapeutics
Sep 21, 2023
Maintains: Speculative Buy
Price Target: $960 → $240
Current: $0.62
Upside: +38,672.21%
STAAR Surgical Company
Sep 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $47.42
Upside: -
Biofrontera
Aug 31, 2023
Reiterates: Buy
Price Target: $18
Current: $0.89
Upside: +1,917.94%
Harvard Bioscience
Jun 22, 2023
Reiterates: Speculative Buy
Price Target: $7
Current: $2.78
Upside: +151.80%
Hoth Therapeutics
Jun 20, 2023
Reiterates: Speculative Buy
Price Target: $5
Current: $0.92
Upside: +446.21%
VolitionRx
Feb 1, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.62
Upside: -
Heart Test Laboratories
Aug 8, 2022
Initiates: Speculative Buy
Price Target: $800
Current: $5.06
Upside: +15,710.28%